Page 3 - Precision Diagnostics News Today

The FDA has approved the therascreen PDGFRA RGQ PCR kit for use as a companion diagnostic, co-developed by Qiagen and Blueprint Medicines, to assist in the identification of patients with gastrointestinal stromal tumors who may be candidates to receive avapritinib.

Operator: Good morning. Welcome to the Lantheus Second Quarter 2020 Financial Results Conference Call. This is your operator for todays call.

Lantheus Holdings, Inc. (NASDAQ:LNTH) Q2 2023 Earnings Call Transcript August 3, 2023 Lantheus Holdings, Inc. beats earnings expectations. Reported EPS is $1.54, expectations were $1.33. Operator: Good morning. Welcome to the Lantheus Second Quarter 2020 Financial Results Conference Call. This is your operator for today’s call. [Operator Instructions] This call is being recorded for replay […]

Company Continues to Implement Major Change in Strategy Focused on Acquiring and Operating Accretive Revenue Generating Laboratories and Related...

The decreasing cost of DNA sequencing has contributed to an uptick in genomic sequencing for precision diagnostics in rare diseases.

This company operates in an $84 billion total addressable market that the company sees growing to around $100 billion by 2024.

/PRNewswire/ -- The "Pregnancy Test Kits Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.coms offering. The global...

/PRNewswire/ -- According to Ariztons latest research report, the pregnancy test kits market to grow at a CAGR of 5% during 2022-2028. To Know More, Download...

CHICAGO, April 11, 2023 /PRNewswire/ -- According to Arizton's latest research report, the pregnancy test kits market to grow at a CAGR of 5% during 2022-2028. To Know More, Download the

Operator: Hello and welcome to the Fulgent Genetics Q4 and Fiscal Year 2022 Earnings Conference Call and Webcast. As a reminder, this conference is being recorded.